Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi

Neuroscience Letters

Volumn 357, Issue 1, 2004, Pages 63-67

  Park, Hyo Jin ^a   Seong, Young Mo ^a   Choi, Ju Youn ^b,c   Kang, Seongman ^a   Rhim, Hyangshuk ^b,d  

^a Korea University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sangmyung University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta; HtrA2 Omi; PDZ domain

Indexed keywords

AMYLOID BETA PROTEIN; PDZ PROTEIN; SERINE PROTEINASE; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

EID: 0442323503     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.11.068     Document Type: Article

References (20)

1. Canevari L., Clark J.B., Bates T.E. beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457:1999;131-134.
2. Chen M., Durr J., Fernandez H.L. Possible role of calpain in normal processing of beta-amyloid precursor protein in human platelets. Biochem. Biophys. Res. Commun. 273:2000;170-175.
3. Fonte V., Kapulkin V., Taft A., Fluet A., Friedman D., Link C.D. Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc. Natl. Acad. Sci. USA. 99:2002;9439-9444.
4. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van Der Ploeg L.H., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni R.J., Roy S., Nicholson D.W. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell. 97:1999;395-406.
5. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
6. Gray C.W., Ward R.V., Karran E., Turconi S., Rowles A., Viglienghi D., Southan C., Barton A., Fantom K.G., West A., Savopoulos J., Hassan N.J., Clinkenbeard H., Hanning C., Amegadzie B., Davis J.B., Dingwall C., Livi G.P., Creasy C.L. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem. 267:2000;5699-5710.
7. Hegde R., Srinivasula S.M., Zhang Z., Wassell R., Mukattash R., Cilenti L., DuBois G., Lazebnik Y., Zervos A.S., Fernandes-Alnemri T., Alnemri E.S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277:2002;432-438.
8. Kim H.S., Lee J.H., Lee J.P., Kim E.M., Chang K.A., Park C.H., Jeong S.J., Wittendorp M.C., Seo J.H., Choi S.H., Suh Y.H. Amyloid beta peptide induces cytochrome c release from isolated mitochondria. NeuroReport. 13:2002;1989-1993.
9. Li W., Srinivasula S.M., Chai J., Li P., Wu J.W., Zhang Z., Alnemri E.S., Shi Y. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat. Struct. Biol. 9:2002;436-441.
10. Lu D.C., Rabizadeh S., Chandra S., Shayya R.F., Ellerby L.M., Ye X., Salvesen G.S., Koo E.H., Bredesen D.E. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat. Med. 6:2000;397-404.
11. Martins L.M., Iaccarino I., Tenev T., Gschmeissner S., Totty N.F., Lemoine N.R., Savopoulos J., Gray C.W., Creasy C.L., Dingwall C., Downward J. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277:2002;439-444.
12. Mochizuki A., Tamaoka A., Shimohata A., Komatsuzaki Y., Shoji S. Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet. 355:2000;42-43.
13. Parks J.K., Smith T.S., Trimmer P.A., Bennett J.P. Jr, Parker W.D. Jr. Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J. Neurochem. 76:2001;1050-1056.
14. Rodrigues C.M., Sola S., Silva R., Brites D. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol. Med. 6:2000;936-946.
15. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
16. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell. 8:2001;613-621.
17. Verhagen A.M., Silke J., Ekert P.G., Pakusch M., Kaufmann H., Connolly L.M., Day C.L., Tikoo A., Burke R., Wrobel C., Moritz R.L., Simpson R.J., Vaux D.L. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277:2002;445-454.
18. Wirths O., Multhaup G., Czech C., Blanchard V., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 316:2001;145-148.
19. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., Stern D. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 389:1997;689-695.
20. Yin K.J., Lee J.M., Chen S.D., Xu J., Hsu C.Y. Amyloid-beta induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J. Neurosci. 22:2002;9764-9770.